Consensus Astrana Health, Inc. Börse Stuttgart

Stocks

3AM

US03763A2078

Healthcare Facilities & Services

Delayed Börse Stuttgart 07:47:40 2026-10-08 EDT			5-day change	1st Jan Change
32.80 ^EUR	-1.20%		+5.73%	+56.60%

10-07	Alignment Healthcare Introduces Its Medicare Advantage Plan to Three New California Counties	MT
09-23	US companies face rise in cyber attacks	RE

caf185a46c6a2.TJoNWLG3I4JfWHNrcgnZU2-Iz7Xj1j3FwsIUVwf68gI.B8B9N_DuRdg5FEQZIT6pAVnKiYOUgHqkjYhgJF69uzca2Tgd_f90zTkcAA~30f140f6e54d8ae26b51668dd9dd0bcc

Analysts' recommendations: Astrana Health, Inc.

09-15	Oppenheimer Initiates Astrana Health at Outperform With $53 Price Target	MT
08-11	Truist Securities Adjusts Price Target on Astrana Health to $55 From $47, Keeps Buy Rating	MT
05-14	Truist Securities Adjusts Price Target on Astrana Health to $47 From $38, Maintains Buy Rating	MT
03-13	Truist Lifts Price Target on Astrana Health to $38 From $37, Keeps Buy Rating	MT
01-06	BofA Adjusts Price Target on Astrana Health to $33 From $40, Maintains Buy Rating	MT
12-12	Needham Initiates Astrana Health With Buy Rating, $28 Price Target	MT
11-12	Truist Lowers Price Target on Astrana Health to $37 From $46, Keeps Buy Rating	MT
25-08-07	Astrana Q2 revenue rises 35% but misses analyst expectations	RE
25-04-01	Barclays Initiates Astrana Health at Equalweight With $36 Price Target	MT
24-12-16	Macquarie Initiates Astrana Health at Neutral With $41 Price Target	MT
24-10-14	TD Cowen Initiates Astrana Health at Buy With $66 Price Target	MT
24-10-11	KeyBanc Initiates Astrana Health at Sector Weight	MT
24-08-08	Truist Securities Raises Price Target on Astrana Health to $59 From $50, Maintains Buy Rating	MT
24-07-11	Top Midday Gainers	MT
24-07-11	Astrana Health Shares Rise After Truist Upgrade	MT
24-07-11	Truist Upgrades Astrana Health to Buy From Hold, Notes Better Visibility, Underappreciated Tailwinds; Lifts PT to $50 From $44	MT
24-06-27	Stifel Adjusts Price Target on Astrana Health to $48 From $45, Maintains Buy Rating	MT
24-05-30	Baird Starts Astrana Health With Outperform Rating, $54 Price Target	MT
24-05-08	Stifel Cuts Price Target on Astrana Health to $45 From $50, Maintains Buy Rating	MT
24-03-01	Truist Securities Adjusts Price Target on Astrana Health to $44 From $41, Maintains Hold Rating	MT
24-02-26	Jefferies Starts Coverage on Apollo Medical With Buy Rating	MT
24-01-24	Stifel Starts Coverage on Apollo Medical with Buy Rating, $45 Price Target	MT
23-12-22	Truist Initiates Apollo Medical With Hold Rating, Price Target is $41	MT
23-10-17	BTIG Initiates Apollo Medical at Buy Rating With $45 Price Target	MT
23-04-12	BofA Securities Initiates Apollo Medical at Neutral With $44 Price Target	MT

More recommendations

Other Healthcare Facilities & Services

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	CVS HEALTH CORPORATION					+31.62%
	HCA HEALTHCARE, INC.					+4.58%
	NATERA, INC.					-3.95%
	FRESENIUS SE & CO. KGAA					+28.42%
	LABCORP HOLDINGS INC.					+10.33%
	QUEST DIAGNOSTICS INCORPORATED					+9.25%
	DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY					+17.08%
	TENET HEALTHCARE CORPORATION					+9.81%
	REDE D'OR SÃO LUIZ S.A.					+10.02%
	Average					+13.02%
	Weighted average by Cap.					+14.36%